Emerald Health Therapeutics Inc (CVE:EMH) Focus On Downstream Product Development

Emerald Health Therapeutics Inc (CVE:EMH) reported that the extract-based market has been growing rapidly and is anticipated to be a notable part of the adult use industry. The company considers that beyond simple extraction, pharma quality formulations boosted by clinical Research & Development will be the next development in the medical cannabis industry.

Such formulations can provide repeatedly predictable, steady dosing and other characteristics anticipated by the medical community. They consider that achieving such attributes exhibits an important necessity and opportunity in advancing a valuable portfolio of intellectual assets that will strengthen the firm’s position as a valued and recognizable medical brand in Canada and may result in future global opportunities.

The highlights

Emerald has extraction-based offerings for the medical market but vital measures are required to accomplish industrial-scale extraction and the quality benchmark and processing capability for pharma quality formulations. The company undertook a major first step by establishing its JV with Village Farms, which will enhance raw material supply for downstream extraction-based offering development. It is also taking measures toward scaling extraction and other procedures to fulfill the demand and product criteria for imminent non-medical and medical extraction-based products.

The management’s end vision is to make Emerald a major Canadian supplier of both wholesale and branded cannabis offerings. Emerald has the mechanisms in place to support customers countrywide and has sales spread out through the nation, with an excellent client service record. With considerably expanded customer demand anticipated in conjunction with decriminalization of the adult-use market in the coming year, Emerald is advancing toward multi-channel distribution to support the important production position it is striving for with internal as well as joint venture capacity expansion and product development measures.

Emerald Health manages its operations majorly through its wholly owned subsidiary known as Emerald Health Botanicals Inc. It is authorized to manufacture and sell both medical cannabis oils and dried medical cannabis flowers in Canada.

Duncan Trigoboff

Duncan Trigoboff

Duncan has 13 years of experience in the investment industry. He has pursued his studies in Germany, where he has graduated in Business and Economics.